Differences in human milk peptide release along the gastrointestinal tract between preterm and term infants

Robert L Beverly1, Robert K Huston2, Andi M Markell2

  • 1School of Biological and Population Health Sciences, Oregon State University, Corvallis, OR, USA.

Insights

Preterm infants show higher total milk peptide release in the stomach compared to term infants. However, term infants release more specific bioactive peptides, indicating different digestion patterns in the infant gastrointestinal tract.

Area of Science:

  • Neonatal nutrition
  • Gastrointestinal physiology
  • Proteomics

Background:

  • Infants born preterm have underdeveloped gastrointestinal tracts, impacting human milk protein digestion.
  • Bioactive peptides from human milk digestion may benefit infant development.
  • The effect of prematurity on peptide release throughout the infant gastrointestinal tract is not well understood.

Purpose of the Study:

  • To compare milk peptide release from milk to stomach to stool between preterm and term infants.
  • To investigate how prematurity influences total and bioactive peptide profiles in the infant gut.

Main Methods:

  • Milk, gastric, and stool samples were collected from preterm (early and late) and term infants.
  • Milk peptides were extracted and identified using Orbitrap mass spectrometry.
  • Peptide abundance and count were compared across digestion stages and infant groups.

Main Results:

  • Total milk peptide count and abundance increased from milk to stomach, then decreased in stool, with similar patterns between groups in milk and stool.
  • Preterm infants in early collection showed significantly higher gastric peptide abundance and count.
  • Term infants had higher abundance of a specific antimicrobial peptide in gastric samples compared to preterm infants.

Conclusions:

  • Preterm and term infants exhibit distinct milk protein digestion patterns in their gastrointestinal tracts.
  • While preterm infants release more total peptides in the stomach, term infants release specific bioactive peptides at higher levels.
  • A conserved C-terminal region of beta-casein releases antimicrobial peptides throughout digestion in infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
174
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.9K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
624
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
110